Sfx Entertainment Inc (SFXE) 0.01 $SFXE Music festival

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sfx Entertainment Inc (SFXE) 0.01 $SFXE

Music festival promoter SFX files for bankruptcy protection
AP - Mon Feb 01, 1:31PM CST
NEW YORK (AP) — The company behind the Electric Zoo and Tomorrowland music festivals has filed for Chapter 11 bankruptcy protection.
SFXE: 0.01 (-0.02)

SFX Entertainment Enters Into Restructuring Support Agreement; Receives $115 Million Financing
GlobeNewswire - Mon Feb 01, 3:53AM CST
SFX Entertainment, Inc. (NASDAQ:SFXE) (the "Company" today announced that it has reached an agreement with an ad hoc group of bondholders ("ad hoc group" to significantly restructure the Company's outstanding debt. SFX and the ad hoc group have entered into a Restructuring Support Agreement ("RSA" that will eliminate more than $300 million in debt from its balance sheet, provide significant working capital and convert the majority of the bondholder group debt into equity in a newly strengthened private company.
SFXE: 0.01 (-0.02)

SFX Entertainment Closes $20 Million Financing
Thomson Reuters ONE - Fri Jan 15, 8:46AM CST
NEW YORK, Jan. 15, 2016 (GLOBE NEWSWIRE) -- SFX Entertainment, Inc. (NASDAQ:SFXE) (the "Company" announced that it has secured $20 million in new financing for itself and certain of its operating subsidiaries, obtaining capital for its working and general corporate purposes.
SFXE: 0.01 (-0.02)

NightCulture & Disco Donnie Presents Announce 2nd Annual Something Wonderful Music Festival at Texas Motor Speedway
GlobeNewswire - Wed Jan 13, 8:45AM CST
NightCulture Inc. (the "Company" (OTCBB:NGHT) and Disco Donnie Presents, an SFX Entertainment (Nasdaq:SFXE) subsidiary, have announced their 2 annual electronic music festival, "Something Wonderful", scheduled to take place at the Texas Motor Speedway located in the Dallas-Fort Worth Metroplex. The event will be held Saturday, April 23, 2016. Early bird tickets are on sale at http://www.SomethingWonderful.com. Artist lineups will be announced in the coming weeks.
SFXE: 0.01 (-0.02)

SFX Entertainment Reports Third Quarter Financial Results
BusinessWire - Mon Nov 09, 5:20PM CST
SFX Entertainment, Inc. (NASDAQ:SFXE) today reported financial results for the three and nine months ended September 30, 2015.
SFXE: 0.01 (-0.02)

DEADLINE ALERT: Lundin Law PC Announces Securities Class Action against SFX Entertainment, Inc. and Strongly Advises Shareholders with Losses in Excess of $50,000 to Contact the Firm
BusinessWire - Wed Nov 04, 6:02PM CST
Lundin Law PC announces that a lawsuit has been filed against SFX Entertainment, Inc. ("SFX" or the "Company" (NASDAQ:SFXE) concerning possible violations of federal securities laws between February 25, 2015 and August 17, 2015. Investors who purchased or otherwise acquired shares should contact the Firm in advance of the November 10, 2015, lead plaintiff motion deadline.
SFXE: 0.01 (-0.02)

Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against SFX Entertainment, Inc. and Lead Plaintiff Deadline November 10, 2015
ACCESSWIRE - Wed Nov 04, 9:01AM CST
NEW YORK, NY / ACCESSWIRE / November 4, 2015 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court for the Southern District of New York on behalf of those who purchased shares of SFX Entertainment, Inc. ("SFX" or the "Company" (NasdaqGS: SFXE), during the period between February 25, 2015 and August 17, 2015 inclusive. (the "Class Period" .
SFXE: 0.01 (-0.02)

Shareholder Notice: Lundin Law PC Announces Ongoing Investigation of SFX Entertainment, Inc. and Strongly Advises Shareholders with Losses in Excess of $50,000 to Contact the Firm
BusinessWire - Tue Nov 03, 8:11PM CST
Lundin Law PC announces it is investigating claims against SFX Entertainment, Inc. ("SFX" or the "Company" (NASDAQ:SFXE) concerning possible violations of federal securities laws between February 25, 2015 and August 17, 2015. The investigation is related to allegations that certain statements issued by SFX were false and misleading concerning the Company's financial performance.
SFXE: 0.01 (-0.02)

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of SFX Entertainment, Inc. Investors
BusinessWire - Fri Oct 30, 10:52AM CDT
Glancy Prongay & Murray LLP ("GPM" announces the filing of a class action lawsuit on behalf of investors of SFX Entertainment, Inc. ("SFX" or the "Company" (Nasdaq: SFXE) who purchased shares between February 25, 2015 and August 17, 2015, inclusive (the "Class Period" and have been damaged by the recent declines in the Company's stock price. SFX investors have until November 10, 2015 to file a lead plaintiff motion.
SFXE: 0.01 (-0.02)

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against SFX Entertainment, Inc. and Lead Plaintiff Deadline November 10, 2015
PR Newswire - Thu Oct 29, 9:13AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court for the Southern District of New York on behalf of those who purchased shares of SFX Entertainment, Inc. ("SFX" or the "Company" (NasdaqGS: SFXE), during the period between February 25, 2015 and August 17, 2015 inclusive. (the "Class Period" .
SFXE: 0.01 (-0.02)

SFX ENTERTAINMENT, INC. SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against SFX Entertainment, Inc. -- SFXE
GlobeNewswire - Tue Oct 27, 4:27PM CDT
The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against SFX Entertainment, Inc. (Nasdaq:SFXE) ("SFX" or the "Company" on behalf of purchasers of the Company's securities between February 25, 2015 and August 17, 2015, inclusive (the "Class Period" .
SFXE: 0.01 (-0.02)

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of SFX Entertainment, Inc. Of Upcoming Deadline
BusinessWire - Mon Oct 26, 6:00AM CDT
Rigrodsky & Long, P.A.:
SFXE: 0.01 (-0.02)

SFX Entertainment Special Committee Provides Update on Sale Process
BusinessWire - Thu Oct 22, 6:45AM CDT
The Special Committee of the Board of Directors of SFX Entertainment, Inc. (NASDAQ: SFXE) (the "Company" announced that it has received preliminary indications of interests from parties interested in acquiring the Company, including a preliminary bid from Robert F.X. Sillerman ("Sillerman" , the Company's Chairman and Chief Executive Officer. The committee is not disclosing the terms contained in these preliminary indications of interest at this time. Mr. Sillerman's preliminary bid was publicly filed with the Securities and Exchange Commission in an amendment to his Schedule 13D. The committee is evaluating the indications of interests and is in discussions with those parties concerning the next steps in the process. The committee expects to finalize the bidding process as expediently as possible.
SFXE: 0.01 (-0.02)

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims against SFX Entertainment, Inc. on Behalf of Investors
BusinessWire - Wed Oct 21, 11:04PM CDT
Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by SFX Entertainment, Inc. ("SFX" or the "Company" (NASDAQ: SFXE). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
SFXE: 0.01 (-0.02)

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of the Board of Directors of SFX Entertainment, Inc.
BusinessWire - Mon Oct 19, 8:35PM CDT
Law Office of Brodsky & Smith, LLC announces an investigation of the Board of Directors of SFX Entertainment, Inc. ("SFX or the "Company" (Nasdaq: SFXE) for potential violations of federal securities laws and breaches of the Board's fiduciary duties.
SFXE: 0.01 (-0.02)

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against SFX Entertainment, Inc. and Advises Shareholders with Losses to Contact the Firm
BusinessWire - Wed Oct 14, 8:54PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against SFX Entertainment, Inc. ("SFX" or the "Company" (SFXE), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between February 25, 2015 and August 17, 2015, inclusive (the "Class Period" , have until November 10, 2015 to serve as lead plaintiff in the class action.
SFXE: 0.01 (-0.02)

Music & Entertainment Sector Showing Signs of 4th Qtr Growth Potential with Recent Acquisitions, Expansions and New Product Announcements
PR Newswire - Tue Oct 13, 7:25AM CDT
Music Streaming, Product Stores and Industry Production Enterprises focus on becoming more competitively positioned for 4th Quarter as positive development of operations and expansions fuel revenue potential growth. Companies in focus with recent developments are Ovation Music & Studios, Inc. (OTC: OVMS), Pandora Media Inc. (NYSE: P), SFX Entertainment, Inc. (NASDAQ: SFXE), EMC Corporation (NYSE: EMC) and Sony Corp. (NYSE: SNE)
P: 13.28 (+0.44), SNE: 30.59 (+0.51), EMC: 27.51 (+0.18), SFXE: 0.01 (-0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of SFX Entertainment, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of November 10, 2015 -- SFXE
GlobeNewswire - Mon Oct 12, 1:44PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
SFXE: 0.01 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading